The zinc finger transcription factor Egr-1 is upregulated in arsenite-treated human keratinocytes

Journal of Molecular Medicine

Volumn 82, Issue 8, 2004, Pages 530-538

  Al Sarraj, Alia ^a,b   Thiel, Gerald ^b,c,d,e  

^a DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d ROCKEFELLER UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Arsenite; c Jun; Egr 1; Epidermal growth factor receptor; Extracellular signal regulated kinase; HaCaT

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AG 1487; ARSENIC TRIOXIDE; CARCINOGEN; EGF RECEPTOR SPECIFIC TYROSINE KINASE INHIBITOR; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN C JUN; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 2; ARSENITES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMEDIATE-EARLY PROTEINS; KERATINOCYTES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; UP-REGULATION; ZINC FINGERS;

EID: 4344668460     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0545-0     Document Type: Article

References (41)

1. Smith AH, Lopipero PA, Bates MN, Steinmaus CM (2002) Public health. Arsenic epidemiology and drinking water standards. Science 296:2145-2146
2. Hartwig A, Groblinghoff UD, Beyermann D, Natarajan AT, Filon R, Mullenders LH (1997) Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated fibroblasts. Carcinogenesis 18:399-405
3. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenbauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr (1998) Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124-133
4. Chen Y-C, Lin-Shiau S-Y, Lin J-K (1998) Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177:324-333
5. Zhu X-H, Shen Y-L, Jing Y-K, Cai X, Jia P-M, Huang Y, Tang W, Shi G-Y, Sun Y-P, Dai J, Wang Z-Y, Chen S-J, Zhang T-D, Waxman S, Chen Z, Chen G-Q (1999) Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst 91:772-778
6. Namgung U, Xia Z (2000) Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J Neurosci 20:6442-6451
7. Ling Y-H, Jiang J-D, Holland JF, Perez-Soler R (2002) Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol 62:529-538
8. Kitchin KT (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172:249-261
9. Schwartz RA (1997) Arsenic and the skin. Int J Dermatol 36:241-250
10. Germolec DR, Spalding J, Boorman GA, Wilmer, JL, Yoshida T, Simeonova PP, Bruccoleri A, Kayama F, Gaido K, Tennant R, Burleson F, Dong W, Lang RW, Luster MI (1997) Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mut Res 386:209-218
11. Germolec DR, Spalding J, Yu H-S, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, Luster MI (1998) Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol 153:1775-1785
12. Hei TK, Liu SX, Waldren C (1998) Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA 95:8103-8107
13. Cavigelli M, Li WW, Lin A, Su B, Yoshika K, Karin M (1996) The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15:6269-6279
14. Liu Y, Guyton KZ, Gorospe M, Xu Q, Lee JC, Holbrook NJ (1996) Differential activation of ERK, JNK/SAPK and p38/ CSBP/RK MAP kinase family members during the cellular response to arsenite. Free Radic Biol Med 21:771-781
15. Liu SX, Athar M, Lippai I, Waldren C, Hei TK (2001) Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci USA 98:1643-1648
16. Lynn S, Shiung J-N, Gurr J-R, Jan KY (1998) Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med 24:442-449
17. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinocytes in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771
18. Thiel G, Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 19:287-292
19. Rolli M, Kotlyarov A, Sakamoto KM, Gaestel M, Neininger A (1999) Stress-induced stimulation of early growth response-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase-2 independent manner. J Biol Chem 274:19559-19564
20. Souza K, Maddock DA, Zhang Q, Chen J, Chiu C, Mehta S, Wan Y (2001) Arsenite activation of PI3K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes. Mol Med 7:767-772
21. Kaufmann K, Thiel G (2002) Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 85:381-391
22. Thiel G, Kaufmann K, Magin A, Lietz M, Bach K, Cramer M (2000) The human transcriptional repressor protein NAB1: expression and biological activity. Biochim Biophys Acta 1493:289-301
23. Groot M, Boxer LM, Thiel G (2000) Nerve growth factor and epidermal growth factor regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. Eur J Cell Biol 79:924-935
24. Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and She. Mol Cell Biol 18:5178-5188
25. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689
26. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI (2000) Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60:3445-3453
27. Rodeck U, Jist M, Kari C, Shih D-T, Lavker RM, Ewert DL, Jensen PJ (1997) EGF-R dependent regulation of keratinocyte survival. J Cell Sci 110:113-121
28. L. Oncogene 16:1493-1499
29. Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL (1999) Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. J Biol Chem 274:17612-17618
30. XL expression through a MEK-dependent pathway. J Biol Chem 276:6320-6326
31. Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Häfner H, Neufeld B, Han J, Rapp UR (1998) The stress inducer arsenite activates mitogen-activated protein kinases extracellular signalregulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273:1917-1922
32. 2 terminal kinase-dependent, p53-independent pathway. Cancer Res 59:3053-3058
33. Kim J-Y, Choi J-A, Kim T-H, Yoo Y-D, Kim J-I, Lee YJ, Yoo S-Y, Cho C-K, Lee Y-S, Lee S-J (2002) Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol 190:29-37
34. Huang C, Ma W-Y, Li J, Goranson A, Dong Z (1999) Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem 274:14595-14601
35. Schmidt M, Goebeler M, Posern G, Feller SM, Seitz CS, Bröcker E-B, Rapp UR, Ludwig S (2000) Ras-independent activation of the Raf/MEK/ERK pathway upon calcium induced differentiation of keratinocytes. J Biol Chem 275:41011-41017
36. Lim CP, Jain N, Cao X (1998) Stress-induced immediate-early, Egr-1, involves activation of p38/JNK1. Oncogene 16:2915-2926
37. Sgambato V, Vanhoutte P, Pagès C, Regard M, Hipskind R, Besson M-J, Caboche J (1998) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci 18:214-226
38. Cibelli G, Policastro V, Rössler OG, Thiel G (2002) Nitric oxide-induced programmed cell death in human neuroblastoma cells is accompanied by the synthesis of Egr-1, a zinc finger transcription factor. J Neurosci Res 67:450-460
39. Rössler OG, Thiel G (2004) Brain-derived neurotrophic factor, epidermal growth factor, or A-Raf induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase. Am J Physiol Cell Physiol 286:C1118-C1129
40. Riggs PK, Rho O, DiGiovanni J (2000) Alteration of Egr-1 mRNA during multistage carcinogenesis in mouse skin. Mol Carcinogen 27:247-251
41. Liu C, Rangnekar VM, Adamson E, Mercola D (1998) Suppression of growth and transformation and induction of apoptosis by Egr-1. Cancer Gene Ther 5:3-28